1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CYTOMX THERAPEUTICS INC
CytomX Therapeutics Inc
XNAS: CTMX
2.79 0.03 (1.09%)
2.4M
XNAS Volume

XNAS 22 Sep, 2026 12:12 PM (EDT)

Watchlist

Portfolio

Alert

CytomX Therapeutics Inc - CTMX - stock price prediction, stock price target, analyst ratings from 8 analysts

CytomX Therapeutics Inc has a share price target of US$ 12, revenue growth forecast of -67.2%, and profit growth estimate of -294.8% for FY26, based on top 8 analyst calls.